Inspired by these studies on their potential beneficial effects in anti-tumor therapy, we genetically engineered murine mastocytoma line P815 with light-switchable modules (named P815-IFNG) to produce murine IFNG and CXCL10. The gene discussed is CXCL10; the disease is mastocytoma.